Alphagan P ALPHAGAN P - Prescribing Info PDF
Font SizeSize 1Size 2Size 3right
Get Adobe Acrobat Reader
About Glaucoma
Glossary

In the early stages of open-angle glaucoma, there are usually no symptoms. Most people are not aware that they have glaucoma until it is diagnosed by an eye doctor. That’s why it is so important that you keep your annual eye appointment. Although glaucoma can affect anyone, you may be at greater risk if one or more of the following describes you:

Risk Checklist

The best way to find out if you have glaucoma is to schedule an appointment with your eye doctor.

 

 
spacer
ALPHAGAN® P ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
 
Important Safety Information
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% should not be used in patients receiving monoamine oxidase (MAO) inhibitor therapy. Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, ocular redness, and itching. Adverse events occurring in approximately 5% to 9% included: burning sensation, increased ocular lymph nodules, increased ocular pressure, ocular allergic reaction, dry mouth, and blurred vision.

Please click here for full Prescribing Information.
spacer